Junfang Xu
- Cancer Research top 2%
- Molecular Biology top 10%
- Immunology top 5%
- Epidemiology
- Infectious Diseases
- Topics
- interferon and immune responses (8 papers)Cancer-related molecular mechanisms research (6 papers)Immune cells in cancer (4 papers)
- Journals
- ScienceImmunityMolecular Cell
- Partner nations
- ChinaCroatiaUnited States
In The Last Decade
Junfang Xu
18 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 94
- Cancer Research 1.1k
- Molecular Biology 1.0k
- Immunology 458
- Epidemiology 178
- Infectious Diseases 106
Countries citing papers authored by Junfang Xu
This map shows the geographic impact of Junfang Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junfang Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junfang Xu more than expected).
Fields of papers citing papers by Junfang Xu
This network shows the impact of papers produced by Junfang Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junfang Xu. The network helps show where Junfang Xu may publish in the future.
Co-authorship network of co-authors of Junfang Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Junfang Xu. A scholar is included among the top collaborators of Junfang Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junfang Xu. Junfang Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | Nonenzymatic lysine d-lactylation induced by glyoxalase II substrate SLG dampens inflammatory immune responsesbreakdown → | 24 |
| 3 | 1 | |
| 4 | 3 | |
| 5 | 7 | |
| 6 | 3 | |
| 7 | 32 | |
| 8 | 4 | |
| 9 | 46 | |
| 10 | 1 | |
| 11 | 9 | |
| 12 | 26 | |
| 13 | 57 | |
| 14 | 1 | |
| 15 | 32 | |
| 16 | 240 | |
| 17 | 30 | |
| 18 | The STAT3-Binding Long Noncoding RNA lnc-DC Controls Human Dendritic Cell Differentiationbreakdown → | 884 |
| 19 | 107 |
About Junfang Xu
Junfang Xu is a scholar working on Immunology, Cancer Research and Infectious Diseases, having authored 19 papers that have together received 1.5k indexed citations. Recurring topics across this work include interferon and immune responses (8 papers), Cancer-related molecular mechanisms research (6 papers) and Immune cells in cancer (4 papers). The work is most often cited by research in Cancer Research (1.1k citations), Immunology (458 citations) and Molecular Biology (1.0k citations). Junfang Xu has collaborated with scholars based in China, Croatia and United States. Frequent co-authors include Xuetao Cao, Pin Wang, Qiuyan Liu, Cong Wu, Yiquan Xue, Lin Li, Yanmei Han, Sheng Xu, Zhengping Jiang and Yujia Wang. Their work appears in journals such as Science, Immunity and Molecular Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.